Short Summary
Motorola Solutions and STA Group settled their IPR dispute over Patent 9,319,852, leading to a joint motion that terminated the proceeding. The Board granted the motion and ordered the settlement agreements to be kept confidential.
Detailed Summary
In IPR2024-00511 concerning U.S. Patent 9,319,852, Motorola Solutions, Inc. and STA Group LLC reached a settlement that resolved all underlying disputes. The parties filed a Joint Motion to Terminate the inter partes review, accompanied by a Binding Term Sheet and Settlement and License Agreement, which they sought to keep confidential. The Patent Trial and Appeal Board, after determining that good cause existed, granted the motion, terminated the IPR with respect to both parties, and ordered the settlement documents to be treated as business confidential information, making them available only to federal agencies or upon a showing of good cause.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Motorola Solutions, Inc. vs STA Group, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Alertus Technologies, LLCvsDesktop Alert, Inc.
The PTAB denied the IPR petition filed by Alertus Technologies against Desktop Alert, Inc.'s patent (9172765). The Board found that the petitioner failed to demonstrate a reasonable likelihood of prevailing on its obviousness and anticipation challenges.
Apple, Inc.vsTHL Holding Company, LLC
Apple’s IPR against THL Holding’s patent 11,350,246 concluded with an adverse judgment after the patent owner disclaimed all challenged claims. The Board entered judgment against claims 20‑27 and terminated the proceeding.
MOTOROLA SOLUTIONS, INC. et al.vsStellar, LLC
The PTAB granted institution for the IPR proceeding, finding a reasonable likelihood of success for Motorola Solutions against Stellar LLC. The Board found sufficient evidence that combining prior art references would teach the challenged limitations, moving the case toward substantive obviousness analysis.
Imperative Care, Inc.vsINARI MEDICAL, INC.
Imperative Care has successfully instituted an IPR against Inari Medical’s 11,844,921 B2 hemostasis valve patent, asserting unpatentability under §§102 and 103 based on Schaffer, Hartley, and Eller. The Board found a reasonable likelihood of success and ordered review of all challenged claims.
3D Diagnostix, Inc.vsWatson Guide IP, LLC
3D Diagnostix successfully petitioned to institute IPR against Watson Guide IP regarding dental prosthesis claims under 103. The Board found sufficient evidence of obviousness, despite disputes over claim language and prior art interpretation.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.